NVO
Novo Nordisk A/S
NVO's fundamentals are mixed: it turned 15% of its revenue into free cash flow, but its operating margin fell 3 points to 43%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
OWLT
Owlet, Inc.
There isn't enough reported data to score OWLT yet.
NVO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
NVO's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
OWLT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Under pressure | |
| Unavailable |
OWLT's revenue is currently healthy, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
NVO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 10x | $40.65 | — |
| Cheap | 14x | $53.56 | +32% |
| Fair | 27x | $103 | +154% |
| Expensive | 39x | $152 | +273% |
Historical ranges are pointers, not guarantees.
NVO's PE is 10x, but its earnings don't support one, so it isn't a reliable read right now.
OWLT PE Valuation
OWLT has no meaningful PE right now: it lost money over the past year.
NVO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Growth | |
| Weakening | |
| Limited | |
| Low |
Analysts expect NVO's revenue to grow, but its profitability to weaken. However, they disagree widely on these estimates.
OWLT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
OWLT has the edge over NVO on the outlook, with more favorable earnings and profitability expectations.
NVO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $3.89 | +4.9% |
| Q1 2026 | $4.07 | +17% |
| Q4 2025 | $3.42 | +1.8% |
| Q3 2025 | $3.47 | +10% |
| Q2 2025 | $3.71 | +24% |
| Q1 2025 | $3.49 | +18% |
| Q4 2024 | $3.36 | +21% |
| Q3 2024 | $3.15 | +27% |
NVO has the stronger earnings trend. Trailing diluted EPS is up 4.9% for NVO versus OWLT down 234%.
OWLT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2025 | -$3.20 | -$0.82 |
| Q2 2025 | -$3.75 | -$1.14 |
| Q1 2025 | -$1.68 | +$1.82 |
| Q4 2024 | -$2.30 | +$2.23 |
| Q3 2024 | -$2.38 | +$3.57 |
| Q2 2024 | -$2.61 | +$4.88 |
| Q1 2024 | -$3.50 | +$4.34 |
| Q4 2023 | -$4.53 | +$5.41 |
OWLT is still losing money, but far less than before: $3.20 per share over the past year, against $13.28 at its worst in mid-2022.
NVO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $11.7B | +2.1% |
| Q1 2026 | $14.4B | +24% |
| Q4 2025 | $11.8B | -7.6% |
| Q3 2025 | $11.1B | +5.1% |
| Q2 2025 | $11.4B | +13% |
| Q1 2025 | $11.6B | +19% |
| Q4 2024 | $12.7B | +30% |
| Q3 2024 | $10.6B | +21% |
NVO's revenue is growing: $11.7B last quarter, up 2.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 34% | -9 points |
| Q1 2026 | 62% | +12 points |
| Q4 2025 | 40% | -2.8 points |
| Q3 2025 | 32% | -16 points |
| Q2 2025 | 44% | +5.4 points |
| Q1 2025 | 50% | +1 points |
| Q4 2024 | 43% | +2.2 points |
| Q3 2024 | 47% | +1.6 points |
NVO has the edge over OWLT on profitability, with a higher operating margin.
OWLT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $33.9M | +30% |
| Q1 2026 | $22.5M | +6.4% |
| Q4 2025 | $26.6M | +30% |
| Q3 2025 | $32M | +45% |
| Q2 2025 | $26.1M | +26% |
| Q1 2025 | $21.1M | +43% |
| Q4 2024 | $20.5M | -2.5% |
| Q3 2024 | $22.1M | +141% |
OWLT has the edge over NVO on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 5.1% | +13 points |
| Q1 2026 | -24% | -12 points |
| Q4 2025 | -18% | +18 points |
| Q3 2025 | 3.8% | +26 points |
| Q2 2025 | -7.4% | +3.5 points |
| Q1 2025 | -13% | +26 points |
| Q4 2024 | -36% | -22 points |
| Q3 2024 | -22% | +64 points |
OWLT's operating margin was 5.1% last quarter, up 13 points from the same quarter a year ago, near the top of its range since 2020.
NVO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $6.3B | +73% |
| Q1 2026 | $1.8B | +20% |
| Q4 2025 | -$5.4B | -$4.7B |
| Q3 2025 | $4.6B | -2.1% |
| Q2 2025 | $3.6B | -34% |
| Q1 2025 | $1.5B | +89% |
| Q4 2024 | -$632.6M | +$390.5M |
| Q3 2024 | $4.7B | +3.3% |
NVO has the edge over OWLT on cash generation, producing positive trailing cash flow while its opponent burns cash.
OWLT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$631K | +$1.7M |
| Q1 2026 | -$5.1M | +$865K |
| Q4 2025 | -$651K | -122% |
| Q3 2025 | -$2.2M | +$5.7M |
| Q2 2025 | -$2.3M | +$1M |
| Q1 2025 | -$5.9M | -$2.6M |
| Q4 2024 | $3M | +$4.6M |
| Q3 2024 | -$7.9M | -$2.7M |
OWLT has burned cash in almost every quarter: −$9M over the past year, against −$13M the year before.
NVO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -12.9M shares |
| 1 year | -0.2% | -11M shares |
| 3 years | -1.5% | -66.8M shares |
| 5 years | -3.8% | -177M shares |
| Available history | -6.5% | -311M shares |
NVO has the edge over OWLT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $520M |
| Q1 2026 | $356.7M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $206.3M |
| Q4 2024 | $1.1B |
| Q3 2024 | $357.4M |
NVO spent $877M buying back its own shares over the past year, down 48% from the year before.
OWLT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.4% | +950K shares |
| 1 year | +85% | +13.1M shares |
| 3 years | +252% | +20.4M shares |
| 5 years | +1289% | +26.5M shares |
OWLT has 29M diluted shares, up 85% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2021 | — |
| Q4 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
NVO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.7x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.4x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
| Q3 2024 | -0.0x | Very low |
NVO's net debt is less than a year of its operating earnings (EBITDA).
OWLT Net Leverage
OWLT's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NVO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 27.0 | Neutral |
NVO's weekly RSI is 43 (neutral) and its Stochastic is 27 (neutral).
OWLT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.1 | Neutral |
| Stochastic | 9.3 | Oversold |
OWLT's weekly RSI is 43 (neutral) and its Stochastic is 9 (oversold).
NVO PE vs Healthcare Sector
| Metric | NVO | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 26x | 60% below |
| PE % | 6 | 29 | 23 pts below |
NVO is trading at 10x earnings, a 60% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
OWLT PE vs Healthcare Sector
OWLT has no meaningful PE right now: it lost money over the past year.
NVO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $39.2 | 3.7% above |
| 20 week MA | $43.9 | 7.4% below |
| 50 week MA | $45.3 | 10% below |
| 100 week MA | $56.3 | 28% below |
| 200 week MA | $80.7 | 50% below |
NVO has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 50% below its 200-week average.
OWLT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.49 | 2.9% above |
| 20 week MA | $5.02 | 8% below |
| 50 week MA | $7.32 | 37% below |
| 100 week MA | $6.92 | 33% below |
| 200 week MA | $5.77 | 20% below |
OWLT has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 20% below its 200-week average.
NVO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.1 | $34.7 | +19% |
| 2021 | $34.7 | $54.2 | +56% |
| 2022 | $54.2 | $67.0 | +24% |
| 2023 | $67.0 | $103.5 | +54% |
| 2024 | $103.5 | $87.4 | -16% |
| 2025 | $87.4 | $52.4 | -40% |
| 2026 YTD | $52.4 | $40.7 | -22% |
NVO has the edge over OWLT on returns for 2026, with the stronger performance.
OWLT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $135.8 | $140.8 | +3.7% |
| 2021 | $140.8 | $40.7 | -71% |
| 2022 | $40.7 | $9.57 | -77% |
| 2023 | $9.57 | $5.28 | -45% |
| 2024 | $5.28 | $4.48 | -15% |
| 2025 | $4.48 | $15.5 | +247% |
| 2026 YTD | $15.5 | $4.62 | -70% |
OWLT's yearly returns have swung widely, from +247% in 2025 to −77% in 2022. It's down 70% so far in 2026.